Why is QMS Medical falling/rising?

As of 23-Sep, QMS Medical Allied Services Ltd is currently priced at 98.85, reflecting a decline of 6.4 points or 6.08%. The stock has underperformed its sector today by 5.66%, and its delivery volume has significantly decreased by 66.67% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has seen a decline of 1.74%, while its performance over the last month shows a positive return of 17.47%. Despite a healthy long-term growth rate in operating profit of 30.17% and an attractive valuation with a PEG ratio of 1.7, the stock has faced challenges, including a substantial drop of 25.40% over the past year, which is significantly worse than the broader market's decline of 2.97%.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as it has underperformed the BSE500, which recorded a negative return of 4.69% over the last year. This underperformance is compounded by flat results in June and a notable increase in interest expenses, which have grown by 88.66% in the last six months. The stock's current trading at a discount compared to its peers may suggest potential value, but the significant decline in price and the lack of investor confidence are likely contributing to its current downward trajectory.